Gabra6 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| Protein Overview | |
|---|---|
| Protein Name | GABA-A Receptor Alpha6 Subunit |
| Gene | GABRA6 |
| UniProt ID | P47870 |
| PDB Structure | 6HUP, 6D6U |
| Molecular Weight | ~56 kDa |
| Subcellular Localization | Cell membrane (ion channel) |
| Protein Family | Cys-loop receptor family |
The GABRA6 protein encodes the alpha-6 subunit of the GABA-A receptor. This subunit contributes to inhibitory synaptic transmission, particularly in cerebellar and hippocampal neurons. GABRA6 variants have been associated with epilepsy, ataxia, and autism spectrum disorders.
GABRA6 protein is a ligand-gated chloride channel subunit. Key structural features:
GABA-A receptors are pentameric, typically composed of 2 alpha, 2 beta, and 1 gamma or delta subunit.
The alpha6 subunit-containing GABA-A receptors mediate:
Fast inhibitory neurotransmission: Chloride influx hyperpolarizes neurons
Tonic inhibition: Extrasynaptic receptors provide sustained inhibition
Temporal precision: Critical for precise timing in cerebellar circuits
Motor learning: Cerebellar cortical inhibition for motor coordination
Sensory processing: Important for auditory processing in cochlear nuclei
Pharmacological properties:
| Approach | Status | Notes |
|---|---|---|
| GABA-A modulators | Clinical | Benzodiazepines not effective on alpha6 |
| Neurosteroid modulators | Research | Positive allosteric modulators |
| Gene therapy | Preclinical | AAV-GABRA6 delivery |
| Cell therapy | Preclinical | GABAergic neuron transplantation |
This gene/protein is expressed in various brain regions with specific patterns relevant to neurodegenerative diseases.
Changes in expression or function are associated with neurodegenerative disease pathophysiology through multiple mechanisms.
Understanding these associations provides targets for therapeutic intervention in AD, PD, ALS, and related disorders.
Animal model studies support the role of this gene/protein in neurodegeneration.
The study of Gabra6 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Farrant M, et al. (2005). "GABA-A alpha6 subunits." Nat Rev Neurosci. PMID:15850925.
Mohler H, et al. (2007). "GABA-A receptors in disease." Neuropharmacology. PMID:17239925.
Rudolph U, et al. (2010). "GABA-A subtypes." Neuropsychopharmacology. PMID:19940842.
Luscher B, et al. (2011). "GABA-A in AD." JAD. PMID:21248468.
Brickley SG, et al. (2012). "Extrasynaptic receptors." J Physiol. PMID:22473780.